These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38368648)

  • 1. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
    Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
    Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploratory study of clinical characteristics and gait features of adolescents with hypermobility disorders.
    de Koning LE; Scheper MC; Ploeger HE; Warnink-Kavelaars J; Oosterlaan J; Bus SA; Engelbert RHH
    Gait Posture; 2023 Feb; 100():222-229. PubMed ID: 36638668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Chuchin JD; Ornstein TJ
    Disabil Rehabil; 2024 Sep; 46(18):4234-4245. PubMed ID: 37843031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Multisegment Ankle and Foot Kinematics During Gait in Patients With Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder: A Case-Control Study.
    Vermeulen S; De Mits S; De Ridder R; Calders P; De Schepper J; Malfait F; Rombaut L
    Arthritis Care Res (Hoboken); 2022 May; 74(5):841-848. PubMed ID: 33275840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
    Estrella E; Frazier PA
    Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
    DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
    J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
    Teran-Wodzinski P; Kumar A
    Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
    Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of ADHD and Autism Spectrum Disorder in Children with Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome: A Retrospective Study.
    Kindgren E; Quiñones Perez A; Knez R
    Neuropsychiatr Dis Treat; 2021; 17():379-388. PubMed ID: 33603376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.
    Fernandez A; Jaquet M; Aubry-Rozier B; Suter M; Aybek S; Berna C
    Brain Behav; 2024 Feb; 14(2):e3441. PubMed ID: 38409931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone parameters in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: A comparative cross-sectional study.
    Coussens M; Banica T; Lapauw B; De Wandele I; Rombaut L; Malfait F; Calders P
    Bone; 2023 Jan; 166():116583. PubMed ID: 36243401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An online pain management program for people with hypermobile Ehlers-Danlos Syndrome or hypermobility spectrum disorder: a three-staged development process.
    Chew MT; Ilhan E; Nicholson LL; Kobayashi S; Chan C
    Disabil Rehabil; 2024 May; ():1-11. PubMed ID: 38738812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
    Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
    Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Hypermobile "Ehlers-Danlos Syndrome" and Hypermobile Spectrum Disorder on Interpersonal Interactions and Relationships.
    De Baets S; De Temmerman M; Calders P; Malfait F; Van Hove G; Vanderstraeten G; De Wandele I; Van de Velde D
    Front Rehabil Sci; 2022; 3():832806. PubMed ID: 36188999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Rashed ER; Ruiz Maya T; Black J; Fettig V; Kadian-Dodov D; Olin JW; Mehta L; Gelb BD; Kontorovich AR
    Vasc Med; 2022 Jun; 27(3):283-289. PubMed ID: 35000503
    [No Abstract]   [Full Text] [Related]  

  • 17. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
    Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
    Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trajectory of hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders in older adults.
    Anderson LK; Lane KR
    J Am Assoc Nurse Pract; 2023 Oct; 35(10):605-612. PubMed ID: 37261967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Muscle Strength Change Over Time in Patients With Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder? An Eight-Year Follow-Up Study.
    Coussens M; Calders P; Lapauw B; Celie B; Banica T; De Wandele I; Pacey V; Malfait F; Rombaut L
    Arthritis Care Res (Hoboken); 2021 Jul; 73(7):1041-1048. PubMed ID: 32293111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.
    Garreth Brittain M; Flanagan S; Foreman L; Teran-Wodzinski P
    Disabil Rehabil; 2024 May; 46(10):1936-1953. PubMed ID: 37231592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.